Filing Details
- Accession Number:
- 0000899243-21-042174
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-01 17:01:32
- Reporting Period:
- 2021-10-28
- Accepted Time:
- 2021-11-01 17:01:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1811063 | Nuvation Bio Inc. | NUVB | () | E9 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1641348 | Omega Fund V Gp Manager, Ltd. | 888 Boylston Street, Suite 1111 Boston MA 02199 | No | No | Yes | No | |
1641354 | Omega Fund V, L.p. | 888 Boylston Street, Suite 1111 Boston MA 02199 | No | No | Yes | No | |
1641355 | Omega Fund V Gp, L.p. | 888 Boylston Street, Suite 1111 Boston MA 02199 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-10-28 | 1,015,000 | $9.60 | 27,197,376 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-10-29 | 45,000 | $9.27 | 27,152,376 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.50 to $9.65 inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.26 to $9.28 inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The reported securities are held directly by Omega Fund V, L.P. ("Omega V"). The reported securities may be deemed to be beneficially owned by each of Omega Fund V GP, L.P. ("Omega V GP"), as the general partner of Omega V, and Omega Fund V GP Manager, Ltd. ("Omega V GP Manager"), as the general partner of Omega V GP. Otello Stampacchia, Claudio Nessi and Anne-Mari Paster are all the shareholders and directors of Omega V GP Manager and have shared voting and investment power over the shares held by Omega V. Each of Omega V GP, Omega Fund V GP Manager and the Omega Directors disclaims beneficial ownership of the securities reported herein, except to the extent of its or their pecuniary interest therein, if any.